Scholars Central

Conference abstractPublished 3 Nov 2015

Treatment de-intensification in HPV-associated squamous cell carcinoma of the head and neck (SCCHN)

Authors: Anthony J Cmelak

Vanderbilt Cancer Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: Recent chemo radiation studies in HPV-associated head and neck cancer have resulted in high rates of tumor control compared no traditional tobacco-associated cancers, but significant long term toxicities. This has resulted in strategies to deintensify treatment in Cooperative Group studies, but the appropriate combination of treatments and verification of specification of risk factors is still controversial. Methods & Results: E2399 was phase II trial of chemoradiation, induction paclitaxel/carboplatin followed by paclitaxel/70Gy for organ preservation in locally advanced oropharynx and hypopharynx cancers, as was the first to prospectively reveal a statistically significant improvement in response rate and survival (95% vs 62% at 2 yrs) in HPV+/p16+ patients. As a follow-up phase II trial, E1308 evaluated chemo-responsiveness in p16+ oropharynx cancer using 3 cycles of cisplatin, paclitaxel, and cetuximab; if a cCr was obtained, reduced-dose 54Gy/cetuximab was delivered; patients with 90%. Only one grade >3 late toxicity was observed (gr 3 hypomagnesemia at 30 months). RTOG subset analysis in patients enrolled on R0129 and R0522 showed similarly improved PFS and OS (55% vs. 28% at 2 yrs) in p16+ patients, and efforts to decrease RT dose are ongoing in follow-up studies. Minimally invasive surgical strategies (ECOG 3311) are prospectively evaluating adjuvant dose-de intensification or even observation based on pathologic findings. Discussion: Smoking status and TNM stage are crucial selection criteria for deintensification chemo radiation and minimally invasive surgical strategies in p16+ SCCHN. The appropriate combination and intensity of each treatment modality is under investigation in Cooperative Groups.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Anthony J Cmelak”